Objective: Carvacrol is a naturally occurring monoterpenic phenol that has been suggested to have an action at transient receptor potential cation subfamily M7 (TRPM7) channels, c-aminobutyric acid (GABA A receptors, and sodium channels, and has been shown to be antiinflammatory. Carvacrol is neuroprotective in models of cerebral ischemia in vivo and in vitro, probably through its action at TRPM7 channels. We therefore aimed to determine the effect of carvacrol on status epilepticus (SE), chronic epilepsy, cell death, and post-SE cognitive decline. Methods: We performed long-term, continuous wireless electroencephalography (EEG) monitoring in vivo in rats who underwent perforant path stimulation (PPS) to induce SE and were then randomized to treatment with carvacrol or saline. We also evaluated TRPM7 receptor expression and quantified seizure-induced cell death. The alternating T-maze paradigm was used to assess memory function. Results: Immunostaining showed that TRPM7 channels are widely expressed in neurons within the hippocampus. We found that carvacrol inhibited recurrent SE and early seizures in vivo, but had no detectable effect in the hippocampus on paired-pulse inhibition or the fiber volley, indicating that it was not acting through sodium channel inhibition or GABA receptors. Although the development and severity of chronic epilepsy were not altered by carvacrol, cognitive decline was significantly improved in animals treated with carvacrol. In keeping with preserved memory functions in animals treated with carvacrol, carvacrol had a protective effect against SE-induced cell death in CA1 and hilus, the hippocampal regions most affected by cell loss in the PPS epilepsy model. Significance: Carvacrol, a naturally occurring inhibitor of TRPM7 channels, is a novel, promising treatment to prevent early recurrence of SE, SE-related neuronal damage, and cognitive decline.
Carvacrol is a monoterpenic phenol, which is present in oregano and thyme oil. It has been used widely in the food industry as a flavoring and food preservative. Carvacrol has been shown to have bactericidal, fungicidal, and insecticidal activity. [1] [2] [3] More recently it has been shown to have neuroprotective effects in both in vitro and in vivo animal models of cerebral ischemia, [4] [5] [6] [7] probably through inhibition of transient receptor potential cation subfamily M7 (TRPM7) channels. 6 TRPM7 channels are ubiquitously expressed transmembrane ion channels, which are constitutively active and suppressed by high intracellular concentrations of free magnesium and Mg 2+ ATP, 8 and so act as magnesium sensors.
9 TRPM7 channels are expressed in the brain, 10 where they have been shown to be important in mediating neuronal anoxic cell death. 11 Following initial reports, many studies have supported the importance of TRPM7 channels in brain ischemia. 4, 12 More recently, a pathologic role of TRPM7 channels in traumatic brain injury has been reported. 5 Both brain ischemia and traumatic brain injury are profound tissue injuries resulting in excitotoxicity and overt necrotic cell death. We asked whether this neuroprotective effect extends to prolonged seizure activity (status epilepticus) and its consequences-chronic epilepsy and cognitive decline. Excessive neuronal activity is the hallmark and defining feature of seizures and status epilepticus (SE), 13 and ion channels are crucial in generating such activity. TRPM7 channels therefore may represent an important target in epilepsy, but surprisingly little is known about the role of TRPM7 channels in SE, seizures, epilepsy, and epilepsy comorbidities. Whereas cell death has been a focus of most studies investigating TRPM7 function, studies evaluating the role of TRPM7 channels in the sequelae of neuronal cell death such as memory function are lacking. More recently, the study of TRPM7 channel function has been facilitated through the characterization of potent TRPM7 agonists and antagonists. 7 Transient pharmacologic manipulation of TRPM7 currents is particularly interesting, since global deletion of TRPM7 is lethal 14 and therefore permanent genetic knock down is less attractive as a therapeutic intervention. We show here that carvacrol prevents recurrent SE, early seizures post-SE, and neuronal cell death in the hippocampus. It is notable that carvacrol prevented post-SE memory decline, suggesting that TRPM7 channels are a potential target for future development of drugs for treating SE and its sequelae, and that carvacrol, a well-tolerated, natural oil should be further investigated for use in this condition.
Materials and Methods

Animals
All animal procedures were carried out subject to local ethical approval and followed the United Kingdom Home Office Animal (Scientific Procedures) Act, 1986. Male adult Sprague-Dawley rats (280-310 g; Charles River, U.K.) were housed with a 12 h light-dark cycle and access to food and water ad libitum. The perforant path model of epilepsy was used to model SE and chronic epilepsy in vivo and has been described previously. 15, 16 For the in vitro experiments, rats were culled with isoflurane overdose and then decapitated. To detect a difference of two standard deviations (a clinically significant change) with a power of 0.8-0.9 and an alpha error of 0.05, a sample size of four to six animals per group is needed.
Preparing acute brain slices
After decapitation, the rat brain was quickly removed and 350 lm horizontal brain slices comprising the hippocampus, dentate gyrus, and entorhinal cortex were cut on the vibratome (Leica VT1200S; Leica microsystems, Nussloch, Germany). The slices were stored in aerated (95% O 2 /5% CO 2 ) artificial cerebrospinal fluid (ACSF) containing 126 mM NaCl, 2.5 mM KCl, 0.9 mM NaH 2 PO 4 , 14 mM Dglucose, 2.5 mM CaCl 2 , 1 mM MgCl 2 , and 2.6 mM NaHCO 3 and titrated to an osmolality of 296 mOsm/kg.
Evoked-field EPSP experiments
Evoked extracellular field excitatory postsynaptic potentials (fEPSPs) were recorded from the CA1 region of the hippocampus in combined hippocampal-entorhinal cortex slices in vitro. The recording electrode, a borosilicate glass microelectrode of 1-2 MΩ resistance filled with ACSF, was placed in stratum radiatum (for fEPSP slopes) or stratum pyramidale (for population spikes) of CA1 region. A bipolar stimulating electrode was placed in the Schaffer collaterals/commissural fiber region. Stimulation intensity was set to 0.3-0.8 mA, and single pulses (100 ls width) with 20 s intervals were delivered. After 20 min of recording, drug or vehicle was added to the perfusion solution, and recording continued for another 20 min. Recordings were filtered at 4 kHz, obtained using a MultiClamp 700B amplifier (Molecular Devices, U.S.A.) and digitized at 10 kHz. The LabView (National Instruments, Austin, TX, U.S.A.) software was used for data acquisition and off-line analysis. Population spike data were acquired and analyzed using WinWCP software (John Dempster, University of Strathclyde, Glasgow, United Kingdom).
Electrode implantation-in vivo experiments
All electrodes were purchased from Plastics One Inc, Bilaney Consultants United Kingdom Ltd. • Carvacrol administration has no impact on epileptogenesis, but prevents memory deficits that occur following SE
• Because carvacrol is an TRPM7 antagonist, TRPM7 may play a role in the neuronal death and cognitive decline following SE dentate granule layer. The reference electrode was secured subcutaneously. A single-pulse stimulus of 3.5 mA and 150 ls width was delivered from a Neurolog system (Digitimer Ltd, Welwyn Garden City, United Kingdom) and a stimulus isolator (Digitimer). Recordings were bandpassfiltered at 0.1-50 Hz and recorded using Spike 2 software (Cambridge Electronic Design, Cambridge, United Kingdom). The optimal position for electrodes was determined by adjusting the electrode position to achieve a maximal population (>2 mV population spike).
For those animals that were to undergo continuous EEG monitoring, a Wireless Subcutaneous Transmitter (A3019D, 0.3-160 Hz band-pass, 512 per second sample rate; Open Source Instruments) was implanted subcutaneously in the dorsal part of the rat body. The stimulation electrode was implanted as above. The reference and the recording electrodes were inserted to lie extradurally through drilled holes and held in place with skull screws. The recording electrode was placed 4 mm caudal and 2.5 mm lateral from the bregma to enable recordings from the cortex. The reference electrode was implanted in the contralateral side of the brain.
Subsequently anesthesia was weaned, 5 ml 0.9% w/v saline was administered subcutaneously, and rats were monitored until full recovery.
Induction of SE and carvacrol injection
Seven days to 10 days postoperatively the perforant path was stimulated through the implanted bipolar electrodes. Animals were randomized into three groups: "controls," which underwent surgery but not stimulation; "epileptic saline," which were stimulated and given repeated injections of saline; and "epileptic carvacrol," which were stimulated and given repeated doses of carvacrol (75 mg/kg, i.p.; Sigma Aldrich, United Kingdom).
The stimulation current was set to elicit a population spike that was 50-75% of the maximum. Monopolar 20 Hz stimulation was delivered from a Neurolog system for 2 h after an initial 20 min baseline recording.
During stimulation and subsequent self-sustaining status epilepticus (SSSE), behavior, seizure type, and severity were monitored, recorded for every 15 min, and graded according to the Racine scale. 17 After 2 h stimulation, the recording was continued and monitored for 20 min to ensure that the animal had developed SSSE. Afterwards, diazepam (10 mg/kg, i.p.) was injected and EEG recording continued for 20-30 min to ensure that SSSE was aborted. Following this, the carvacrol group received carvacrol, 75 mg/kg, i.p.. The dose was chosen based on previous experiments in vivo. 4, 18 The epileptic saline group received the same volume of saline (i.p.). Carvacrol is a lipophilic substance and is quickly metabolized and excreted. In rats, only minimal amounts of carvacrol and its metabolites were found in urine 24 h after oral ingestion. 19 Thus, another two doses of carvacrol (epileptic carvacrol group; 75 mg/kg, i.p.) or saline (epileptic saline group) were administered every 8 h, so that each animal received three injections during the first 24 h after SE induction, when neuronal damage is the greatest.
EEG monitoring of seizure activity
Animals that had implanted subcutaneous transmitters were then transferred to a telemetry unit (Open Source Instruments, Inc). Continuous EEG recordings were performed for up to 8 weeks. Neuroarchiver tool in long wire data acquisition (LWDAQ) software (Open Source Instruments, Inc.) was used to record and analyze seizures (see www.opensourceinstruments.com/Electronics/A3018/Se izure_Detection.html).
Seizure analysis
Seizure analysis was carried out in a semiautomated fashion. The Event Classifier program in Neuroarchiver was used to detect seizures. It automatically detects events based on a comparison of preselected events in an event library. The Classifier operates on the baseline power and the interval metrics that have been shown to be superior to coastline analysis. The algorithm was validated by visual EEG seizure analysis and adjusted to detect all seizure events. Each event highlighted by the Event Classifier was visually confirmed by AK, experienced with EEG seizure analysis, to exclude false-positive results; only events lasting ≥20 seconds were included. All data were analyzed off line and the investigator was blinded to treatment group. Seizures were quantified on a weekly basis for 7 weeks starting 1 week after induction of status epilepticus. Seizures were analyzed by AK who was blinded to the animal group.
Immunostaining, imaging, and cell counts
Three weeks to 4 weeks after electrical induction of SSSE, a group of controls, and epileptic saline and epileptic carvacrol groups were perfused with phosphate-buffered saline (PBS) and subsequently 4% paraformaldehyde (PFA). Animals were culled and brains were kept in 4% PFA overnight. For immunohistochemistry, 45 lm coronal slices were cut using a Leica vibratome (Leica Microsystems). To ensure that similar regions within the hippocampus were compared between groups, slices were selected at the same distance (anteroposterior) in all three groups. Slices were incubated with 40,6-diamidino-2-phenylindole (DAPI; 5 lg/ ml; Sigma Aldrich), Neuronal Nuclei protein (NeuN; 1:400; Merck Millipore), and TRPM7 antibody (1:300; Abcam) as appropriate, and secondary antibodies Alexa Fluor 546 (1:500; Molecular probes, Invitrogen) and Alexa Fluor 488 (1:500; Molecular probes, Invitrogen). All images were acquired at a resolution of 1,024 9 1,024 on a confocal microscope (Zeiss 710 VIS LSM, Oberkochen, Germany). The 209 objective was used to image CA1 and CA3 region and dentate gyrus (DG). DAPI emission spectra were imaged at 460 nm using a 405-nm excitation laser. Alexa Fluor 488 was excited with the 488 nm argon laser, and emission was collected at 500-550 nm. Alexa Fluor 546 was excited with the 543 laser measuring light emitted >560 nm. Cell counts were performed by AK blinded to the treatment group. Cells counts were expressed as cell counts per length (CA1 and CA3 area) or as cell densities (see Fig. 4 ; hilar cell counts). In CA1 and CA3 regions, the number of cells per length were counted: for this purpose three areas of 300 lm length each were selected, each~50 lm apart, representing the whole length of CA1/CA3. Cells that were within 45 lm of the main CA1/CA3 cell cluster were also included.
Rewarded alternating T-maze test
To assess memory function, the rewarded alternating T-maze test was used. Perforant path stimulated rats were tested 3-4 months following SE induction. The T-maze (Med Associates, Inc., U.S.A.; United Kingdom distributor: Sandown Scientific, United Kingdom; Standard T-Maze Package for Rat) experiments were conducted with the evaluator blinded to the treatment group and following a modified protocol described by Deacon and Rawlins. 20 The rewarded T-maze test consisted of the following parts: habituation, training, and main experiments. Animal were weighed two subsequent days before starting a restricted diet to obtain a baseline weight. Then animals were weighed on a daily basis to ensure that they maintained 90-95% of their free-feeding body weight. The main training was conducted as follows. Access to the correct choice arm was restricted. Animals were placed in the start arm. The sample arm was baited with one pellet and the choice arm with two pellets. Once animal reached the end of the sample arm and consumed the pellet; it was placed back to the start arm not facing the T junction. Then the door to the choice arm was opened and the animal was allowed to choose an arm (Fig. 4A) . During the main test, the animal was given 60 s retention interval (the time period between exposure to sample and choice phase) before making a choice of arm. The correct arm choices were counted, with the counter blinded to animal group.
Statistical analyses
Statistical analyses (paired t-test, one way analysis of variance [ANOVA], two-way ANOVA, post hoc Tukey test, Fisher exact test, Loglinear mixed model followed by pairwise comparison with sequential Bonferroni correction) were performed using SPSS 17.0 (Chicago, IL, U.S.A.). Shapiro-Wilk and Anderson-Darling tests were carried out to check for normality. The significance level was set at p < 0.05, and all data are given as mean AE standard error of the mean (SEM).
Results
Carvacrol has no effect on fiber volley or paired-pulse inhibition Carvacrol acts on TRPM7 channels, but has also been reported to decrease ion conductance in peripheral sodium channels. 21 Moreover, it has been shown that carvacrol can facilitate the action of low GABA concentrations on GABA A receptors. 22, 23 To determine if these effects are relevant to hippocampal circuitry, we tested the effect of a high carvacrol concentration (1 mM) on fEPSPs in stratum pyramidale (SP) and radiatum (SR) of the CA1 region after stimulation of the Schaffer collaterals. The normalized mean slope of fEPSPs recorded in SR increased significantly during carvacrol treatment compared to baseline (p < 0.05 paired t-test). There was, however, no significant change in fiber volley slope after carvacrol was added (Fig. S1 ), indicating that carvacrol does not affect sodium channels in acute brain slices. There was also no change in paired-pulse inhibition, as measured by population spike amplitude (one way ANOVA), which indicates that carvacrol does not significantly affect GABAergic inhibition (Fig. S2) . 24 
Expression pattern of TRPM7 in the hippocampal formation
We next determined qualitative expression levels of TRPM7 in the hippocampal formation. Although studies have demonstrated that messenger RNA (mRNA) levels of TRPM7 are high throughout the entire brain, 10 there has been no detailed study of neuronal TRPM7 expression in the hippocampus. We therefore co-stained for TRPM7 and NeuN within the hippocampus. This showed that there was robust expression of TRPM7 channels throughout the hippocampal formation (CA1, CA3, and hilus). This co-localized with the NeuN staining indicating that TRPM7 channels are expressed in neurons. TRPM7 channel expression was particularly high in CA1 and was least expressed in CA3, with hilus, and DG showing intermediate expression levels (Fig. 1) .
Carvacrol treatment prevents reoccurrence of early SE SSSE was induced in animals (n = 16) that were then randomized to receive either three doses of saline or carvacrol (total dose 225 mg/kg) over 24 h. One animal dropped out (epileptic saline group) as the headpiece came off soon after stimulation. We first examined any possible antiseizure effect of carvacrol in the first 24 h). In particular, we examined recurrent SE, defined as continuous seizure activity lasting >30 min or repetitive seizures with an interseizure interval of <2 min (e.g., see Fig. 3C ). We found that 12 h after induction of SE, and after diazepam injection as per protocol, six (~86%) of seven animals in the salinetreated group developed recurrent SE. This is in striking contrast to animals that were injected with carvacrol of which two (25%) of eight animals developed recurrent SE (p < 0.05, Fisher exact test; Fig. 2 ).
Carvacrol alters early seizure frequency but not chronic epilepsy
We next analyzed whether there was a difference in the development of epilepsy between the two groups. In the PPS model of epilepsy that we used, animals develop seizures and chronic epilepsy immediately after SE. We quantified the seizure frequency on a weekly basis 1 week after SE; at that time, any acute effects of carvacrol will have passed. 19 A generalized linear model (with a Poisson probability distribution, week as a within-subject effect and treatment as the between-subject factor) was used to compare seizure frequency changes over time between the two groups. Over the whole time period, there was no statistical difference between saline-treated and carvacrol-treated groups (Wald chi-square 1.77, d.f. [1] , p > 0.05). However, the interaction of treatment with week was significant (Wald chi-square 37.8, d.f. [6] , p < 0.001) indicating that there is a difference between the groups depending on the week. Post hoc Mann-Whitney test showed that there was a significant difference in the seizure frequency in only the second week between the epileptic saline and epileptic carvacrol groups ( Fig. 3B ; p < 0.05). Two animals (one saline treated and one treated with carvacrol) had to be excluded after the evaluation of status epilepticus, as there was a problem with the recording equipment after 2 days. The remaining saline-treated animals (n = 6) had a median of five seizures, whereas the animals treated with carvacrol (n = 7) had a median of zero seizures at week 2. This effect was not sustained in the following weeks. Analysis of seizure duration showed that there was no significant difference between epileptic saline and epileptic carvacrol groups (Fig. 3C) .
Carvacrol prevents hippocampal cell death
Although, there was no effect on the development of chronic epilepsy, we asked whether carvacrol had an effect on neuronal death. The greatest cell death in the PPS model is observed in the first 1-2 days following initial SE and continues for 1 week with minimal cell death after this. 25 In separate groups of animals, we quantified neuronal cell death in CA1, CA3, and hilus in controls, epileptic saline, and epileptic carvacrol animals (all n = 6) 3-4 weeks after SE. We observed significant differences between the three groups in both hilar ( Fig. 4C,D; [F 2,15 = 8.28; p < 0.01]) and CA1 regions (Fig. 4A,B; [F 2,15 = 47; p < 0.001]; both one-way ANOVA). There was an~20% reduction of cell counts in CA1 regions (post hoc Tukey test; p < 0.001) and a~50% reduction in the hilus (post hoc Tukey test; p < 0.01) in epileptic saline-treated animals compared to controls. Neuronal cell counts were not significantly different between controls and epileptic carvacrol-treated animals; however, the cell count was significantly higher in the epileptic carvacrol group compared to the epileptic saline group (post hoc Tukey test; p < 0.001), suggesting that inhibition of TRPM7 channels with carvacrol completely prevented neuronal cell death in both CA1 and hilar regions. No significant difference in the degree of cell loss was observed between the three groups in the CA3 area ( Fig. 4E ; one-way ANOVA [F 2,15 = 3.18, p > 0.05,]).
Cognitive decline is prevented by carvacrol
Finally, we asked whether preventing recurrent SE, early seizures, and cell death with the TRPM7 blocker carvacrol has an impact on memory. We tested epileptic saline, epileptic carvacrol, and control animals after~3 months using an alternating reward T-maze protocol (Fig. 5A ). There was a significant difference in the percentage of correct arm choice between the three groups (one-way ANOVA, F 2,14 = 9.7; p < 0.01). The mean percentage of correct arm choices in the T-maze was 95.3 AE 3.9% in controls versus 63.4 AE 14.5% in epileptic saline-treated animals (post hoc Tukey test; p < 0.01), suggesting that spatial memory is impaired in epileptic animals. There was no significant difference between control and epileptic animals treated with carvacrol (post hoc Tukey test; p > 0.05 ;  Fig. 5B) ; however, the mean percentage of correct arm Recurrence of status epilepticus after performant path stimulation. Pie charts summarizing recurrence of status epilepticus in epileptic animals treated with saline (A) and epileptic animals treated with carvacrol (B). Representative EEG trace in an animal with recurrent status epilepticus after performant path stimulation (C). Epilepsia ILAE choices in the epileptic carvacrol group (86.5 AE 15.3%) was significantly higher compared to the epileptic saline group (post hoc Tukey's test; p < 0.05), suggesting that carvacrol was able to entirely prevent seizure-induced memory dysfunction.
Discussion
We have shown that carvacrol, a TRPM7 channel blocker, effectively inhibited recurrent SE and early seizures after SE in the perforant path model of epilepsy, improving disease severity in the early stages. Carvacrol did not prevent subsequent development of chronic epilepsy, but efficiently prevented cognitive decline post-SE.
TRPM7 channels are regulators of magnesium homeostasis. Hypomagnesemia has been documented in patients with epilepsy, 26 and acute symptomatic seizures are precipitated by metabolic conditions that induce hypomagnesemia such as alcohol consumption. 27 In addition, an in vitro epilepsy model-the low magnesium model of epilepsy-exerts its effect through depletion of extracellular magnesium. These findings indicate that magnesium homeostasis is important in epilepsy.
In the current study, we used carvacrol as an inhibitor of TRPM7 channel function. Carvacrol, a food additive, has antimicrobial properties likely via its toxicity against bacterial membranes. 28 In addition, carvacrol also has antiinflammatory effects at high concentrations via PPARc-dependent suppression of COX-2 promoter activity. 29 With particular importance to our study, carvacrol has been shown to be a potent antagonist at TRPM7 channels in vertebrates in addition to being an antagonist at Transient Receptor Potentiallike channels in Drosophila. 6 Carvacrol also activates "thermo" Transient Receptor Potential (TRP) channels: TRPV3 and TRPA1, channels which are expressed at primary sensory nerve terminals such as the tongue and nasal epithelium where they provide information about thermal changes. 30 The action on TRPM7 channels is likely to be their main effect in preventing recurrence of SE, seizures after SE, and cognitive decline in our study. There is, however, a possibility that the antiinflammatory actions of carvacrol might contribute to these effects as well.
In addition, inhibition of peripheral sodium channels by carvacrol has been reported. 21, 31 In our experiments, carvacrol did not inhibit, but indeed potentiated fEPSPs, in hippocampal-entorhinal cortex slices and also had no effect on the fiber volley, suggesting that a significant inhibitory effect on sodium channels did not occur. This could possibly be explained by different variants of sodium channels in peripheral nerves and central nervous system (CNS). Two studies have also suggested that carvacrol has an effect on GABA A receptors exposed to very low GABA concentrations (1-2 lM) 22, 23 ; these concentrations are orders of magnitude lower than GABA concentrations at the synapse. We, therefore, asked whether such an effect is relevant to hippocampal circuitry; carvacrol has no effect on paired-pulse inhibition of population spike amplitude, indicating that carvacrol is having no significant effect on GABAergic inhibition. 24 A recent study indicates that carvacrol has an antiseizure effect, as it completely prevented seizures in the 6 Hz partial seizure model with a median effective dose in 50% of the animals (ED50) of 35.8 mg/kg, i.p. 32 In addition, carvacrol was tested against acute seizures in two additional seizure models. 33 In this study, carvacrol increased the latency for the development of convulsions in the pentylenetetrazol model and prevented tonic convulsions in the maximum electroshock model. These acute antiseizure effects were observed only with concentrations of carvacrol much higher (200 mg/kg, i.p.) than those used in our study. The effects of carvacrol on chronic epilepsy were not investigated in the study. Of interest, despite high doses of carvacrol administered intraperitoneally in their study, Quintans-J unior and colleagues were unable to show a GABA A receptor-related effect, because flumazenil, a potent GABA A receptor antagonist, did not prevent antiseizure effects in their study. Taken together with our results, this suggests that carvacrol does not modulate GABAergic inhibition in vivo and rather supports the notion that carvacrol acts through blocking TRPM7 channels.
To our knowledge there have been no studies looking at modulation of key regulators of magnesium homeostasis such as the TRPM7 channel in chronic epilepsy. However, there are several studies that have looked at the role of TRPM7 channels in brain hypoxia and traumatic brain injury. 4, 5, 12 Those studies show that inhibiting TRPM7 channels is neuroprotective in these conditions. The mechanism by which TRPM7 channels contribute to neuronal death in these conditions has been shown to relate to an increase in Ca 2+ -permeable nonselective cation conductances. 5, 11 We have shown previously that epileptiform activity is characterized by repetitive Ca 2+ oscillations and that prolonged seizure activity leads to Ca 2+ overload and subsequent cell death. 34 It is likely that TRPM7 channels contribute to this process, and that the current findings highlight a neuroprotective effect of the TRPM7 channel blocker carvacrol on hippocampal cell death in an in vivo epilepsy model.
Of interest, we show that blocking TRPM7 channels reduced not only cell death in epilepsy but also early recurrence of status epilepticus. Recurrence of status epilepticus occurs in up to 50% of patients given benzodiazepines. 35 Early seizures after status epilepticus were also suppressed significantly by carvacrol in our study, whereas chronic seizure frequency remained unaltered. Carvacrol is cleared within 24 h, 19 indicating that this effect is not due directly to any acute antiseizure effects of carvacrol. Indeed, these findings imply that acute hyperexcitability/seizures and chronic epilepsy after SE depend on different mechanisms. 36, 37 We found that memory decline after SE as measured by the alternating T-maze test was prevented by inhibiting TRPM7 channels with carvacrol. To our knowledge, this is the first report that shows that blocking TRPM7 channels can prevent the long-term sequelae of neuronal injury. This effect may be mediated through a direct effect on TRPM7 channels or through its suppression of recurrent SE. Previous studies have indicated that suppression of SE, for example, via lamotrigine or valproate, is effective in preventing neuronal cell death and cognitive dysfunction. 38, 39 Moreover, the separation of epileptogenesis from neuronal death and cognitive deficits is supported by other animal studies. 40 The TRPM7 channel antagonist carvacrol is a food additive and has been used previously in animal models of stroke and traumatic brain injury. 4, 5, 18 We chose carvacrol in this study, as it is likely that this is easily translatable into clinical trials in humans. It should be noted that TRPM7 channels are involved in many important physiologic processes such as cytoskeletal organization, cell adhesion, and cell migration, 41 processes that also occur in the adult brain. However, carvacrol is a reversible, short-lasting antagonist at the TRPM7 channel, 6 and so acute administration is unlikely to affect these longer-term processes.
Our findings here indicate that administration of carvacrol, a naturally occurring oil that blocks TRPM7 channels, can improve outcomes after SE, and is a potential disease-modifying treatment.
